Plantar Fasciitis Clinical Trial
Official title:
Plantar Heel Pain: Multisegment Foot Motion and Muscle Function, FFI Translation, and Evaluation of Treatments-Subproject1 Investigation of Multisegmental Foot Motion and Muscle Activity in Patients With PHP Compared to the Normal Healthy Plantar Heel Pain: Effect of Physical Therapy With Strengthening Exercise and With Stretching Exercise in the Plantar Heel Pain Management: a Randomized Control Trial
(Subproject 1) "Plantar heel pain (PHP)" or "plantar fasciitis" is one of the major foot
problems which can occur in any age group. It is a commonly encountered musculoskeletal
problem that can cause disability, activity limitation, discomfort, and affect the quality of
life. It involves pain and inflammation of the plantar fascia, which runs across the bottom
of the foot and connects the heel bone to toes. PHP frequently found in active workers aged
between 25 and 65 years with the highest incidence in people aged between 40 and 60 years.
However, very few studies investigated the alterations of the multisegmental foot motions and
muscle functions in patients with PHP. To prescribe the relevant program of treatment and
reduce the risk of symptoms chronicity, it is necessary to have an in-depth understanding of
changing mechanisms in patients with PHP. To explain how the symptoms occur in patients with
PHP, foot function is another aspect that should be determined. One of the popular
questionnaires determining foot function is the Foot Function Index (FFI) questionnaire. It
has been proved to have good reliability and validity and has been translated into several
languages. To be able to use the international standard questionnaire, it is necessary to
translate the FFI into Thai. This can be implemented in Thailand and be able to compare the
findings of the interventional effect internationally. In addition, very few studies reported
the effectiveness of the treatment program for patients with PHP. Among previous evidences,
the controversial findings existed. Thus, the intervention program should be evaluated for
obtaining the effective treatment for this population.
(Subproject 3) The objectives of the study will be General Objective is to investigate the
effectiveness of strengthening exercise program on symptoms in patients with plantar heel
pain.
Specific Objectives is to compare the effectiveness between physical therapy treatment
program with strengthening exercise and with stretching exercise on foot function score, pain
at worst score, plantar fascia thickness, muscles strength, ankle motion, and gait parameters
in patients with plantar heel pain among baseline, after 4th and 8th of treatments, and after
1st and 2nd month of self-home based exercise.
(Sub-project 1) Procedure
Each participant will attend data collection on a single occasion and allocate into the
healthy or patients with PHP with the selection criteria before enrollment. They will dress
with short pants which researcher prepare. Before testing, the NORAXON TeleMyo Receiver will
be synchronized with the forceplate and video. The real-time signal of motion, EMG, and force
data will simultaneously synchronize and present on the screen.
EMG preparation
The skin will be prepared over the sites for electrode placements by shaving, lightly
abrading, and cleaning with 70% alcohol prior to electrode application. The electrodes will
place 20 mm center to center interelectrode space over the site in each muscle.
Interelectrode impedance is less than 10 kiloohm. The elastic adhesive tape is used to fixed
electrodes to control movement artefacts. Participants will perform reference contractions to
check the placement and cross-talk of the electrodes between EMG signals from different
muscles prior to data collection.
EMG placement
Muscle activation will be measured by electromyography (TeleMyo DTS Telemetry, NORAXON USA
Inc.) at a sampling frequency of 1000 Hz in order to quantify the dynamic muscle function of
the lower extremity. Surface electrodes will be placed according to recommendations of the
European Recommendations for Surface Electromyography (SENIAM). Pairs of wet-gelled bipolar
Ag-AgCl Dual surface electrodes (Ag/AgCl NORAXON Dual electrodes 20 mm spacing) are selected
for surface EMG sensor. The location and orientation of electrode placements are localized in
the supine position by the same researcher. The electrode will be placed on Peroneus longus
(PL) which will be placed at 1/4 on the line between the tip of the fibular and tip of the
lateral malleolus. Tibialis anterior (TA) electrode will be placed at 1/3 on the line between
the tip of the fibular and tip of the medial malleolus. Gastrocnemius medial head (GM) and
Gastrocnemius lateralis (GL) electrodes will be placed on the largest bulb of the muscle at
medial head. All exact position of the muscles will confirm by their actions.
Maximum Voluntary isometric contraction (MVIC) test
Participants perform 5 seconds MVIC against manual resistance in each of the muscle for 3
times. The PL and TA will be assessed in supine lying position and gastrocnemius will be
assessed in standing position. Participants will perform the action of each muscle against
manual resistance from researcher and equipment. The peak amplitude of EMG signal in each
trial will be selected and will be averaged from 3 seconds over the EMG. The peak mean
amplitude of the 3 trials for each muscle will be used for normalization.
Anthropometric data assessment
Anthropometric data will be obtained from each subject for calculating the kinematic and
kinetic data. It includes body height, body weight, leg length, and joint widths of the knee
and ankle. Leg length is the distance between anterior superior iliac spine (ASIS) and medial
malleolus. The knee width is the distance between medial and lateral condyles across the knee
joint. The ankle width is the distance between medial and lateral malleoli.
Marker placement
The lower body markers of Plug-in-Gait will be used in the study to observe lower extremity
motion data during walking. The model consists of left and right anterior superior iliac
crests, left and right posterior superior iliac crests, left and right knees, left and right
thighs, left and right ankles, left and right tibias, left and right toes, left and right
heels. Right back marker will be used for the markers auto-label process in order to
discriminate the left or the right.
Foot model
The markers will be placed on foot bony prominence following the Oxford Foot Model to obtain
multisegmental foot motion during walking. The Oxford Foot Model has been used in previous
studies to determine the multisegmental foot motion (35, 36) and proved to be validated and
reliable (35, 36).
To define the forefoot segment, markers will be placed on the most distal, medial aspect of
the first metatarsal shaft, the most proximal and distal lateral aspects of the fifth
metatarsal shaft, and midway between second and third metatarsal heads. For the rearfoot
segment, markers will be placed on sustentaculum tali, lateral calcaneus, heel (distal part
of the calcaneus), posterior proximal calcaneus and a peg marker will be placed on posterior
calcaneus between the heel and proximal calcaneus markers. For the tibial segment, markers
will be placed on medial malleolus, lateral malleolus, anterior aspect of tibial crest,
tibial tuberosity and head of fibula.
Prior to comparing the foot and ankle kinematic data between patients with PHP and normal
healthy, repeatability of data will be assessed by intraclass correlation coefficient (ICC)
values among trials of walking for ensuring the data can be acceptable, especially in the
pathologic condition of the foot as PHP.
Gait measurement
Participants will walk on the 8-meters walkway until they familiar with the environment of
the laboratory. Then, gait data will be collected for 3 success trials at their comfortable
speed. Motion data will be collected at 100 Hz and will be filtered by using the Butterworth
filtering technique at 5 Hz. Averaged data of EMG and motion from 3 trials will be used for
further analysis.
(Sub-project 3)
This study will recruit patients with Plantar heel pain (PHP) from the Physical Therapy
Center, Faculty of Physical Therapy, Mahidol University. The eligible participants will be
screened and recruited following the inclusion and exclusion criteria. The participants will
be screened according to the criteria. Purposes, procedures, and possible risks of the study
will be explained to the participants. Prior to participating in the study, they will sign in
the informed consent. The participants will be allocated into the group of intervention,
which is the experimental (strengthening) group and the control (stretching) group, according
to the stratified randomization technique. The participants will be assessed all outcomes for
the baseline; pain at worst, FFI, plantar fascia thickness, muscle strength, ankle range of
motion and gait measurement.
After that, all participants will be received the same conservative treatment (therapeutic
ultrasound, tissue mobilization, and joint mobilization) by the experienced physician. Then,
the participants will be instructed to do the exercise following the program of their
allocated group. The experimental group will be performed toe flexor muscle exercise, ankle
evertor muscles exercise, and high-loading strength training, but the control group will be
performed the gastrocnemius muscle, soleus muscle and plantar fascia stretching. All
participants will be treated for 8 times (2 times per week) and perform the home-based
exercise program three times a day. After the treatment end, the participants will continue
their home-based exercise for 2 months. The home-based exercise protocol will be prescribed
by the physical therapist.
The assessment of all outcomes data will perform for 5 times; 1) baseline, 2) after 4th and
3) 8th of treatments, and 4) after 1st and 5) 2nd month of self-home based exercise. The
researcher who evaluates the outcome data will be blinded to the group of participant. They
will be involved only in the admission, randomization, physical examination, and discharge.
All physical therapists will be undergoing the meeting and practical session to clarify the
study protocol and treatment guidelines. To ensure the participants able to do home program
exercise properly, the understanding and compliance will be checked by phone call and record
the number of exercise in the logbook.
The statistical significance will be estimated at probability (p-value < 0.05). The
descriptive statistic will be used to analyze the demographic and baseline characteristics of
the participants. The Kolmogorov- Smirnov Goodness of Fit test will be tested the data
distribution. The baseline data will be compared between groups to investigate the difference
by using the independent t-test and Mann-Whitney U test for normal and non-normal
distribution of data. The outcome measurements are the VAS score, FFI score, gait parameter,
plantar fascia thickness, muscle strength, and ankle ROM will be analyzed by the two-way
repeated ANOVA among baseline, after 4th and 8th of treatments, and after 1st and 2nd month
of self-home based exercise. If the data are not normally distributed, Friedman test will be
used to compare the mean differences.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02546115 -
RCT - Assessing the Benefits of the Use of a Tension Night Splint in Patients With Plantar Fasciitis
|
N/A | |
Unknown status |
NCT01882894 -
Efficacy of a Custom Temporary Foot Orthosis for Plantar Fasciitis Treatment
|
N/A | |
Terminated |
NCT01996111 -
Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis
|
N/A | |
Completed |
NCT01659827 -
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
|
N/A | |
Completed |
NCT00888394 -
Effectiveness of Podiatry on Plantar Pain
|
Phase 4 | |
Completed |
NCT00758641 -
Platelet Rich Plasma to Treat Plantar Fasciitis
|
Phase 4 | |
Terminated |
NCT00527748 -
Foot and Ankle Range of Motion (Stretching) Apparatus
|
N/A | |
Recruiting |
NCT05584046 -
A Single-blind RCT to Investigate the Effect of a Novel Herbal Patch for the Treatment of PF
|
N/A | |
Completed |
NCT04088383 -
Amnios™ RT Outcomes Study
|
N/A | |
Completed |
NCT01994759 -
Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.
|
Phase 4 | |
Completed |
NCT02646579 -
Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only
|
N/A | |
Completed |
NCT05592808 -
Comparison of Taping Techniques in Plantar Fasciitis
|
N/A | |
Not yet recruiting |
NCT04125264 -
Intense Therapeutic Ultrasound (ITU) to Treat Plantar Fasciitis
|
N/A | |
Completed |
NCT02546089 -
ABI v Dry Needling for Plantar Fasciitis
|
N/A | |
Completed |
NCT00765843 -
A Trial of Custom Foot Orthoses for the Treatment of Plantar Heel Pain
|
N/A | |
Completed |
NCT00155324 -
Change and Clinical Significance of Plantar Fascia Thickness After ESWT
|
N/A | |
Completed |
NCT04941469 -
Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot
|
N/A | |
Completed |
NCT06055933 -
Effect of Kinesio Taping and Extracorporeal Shock Wave Therapy on Plantar Fasciitis
|
||
Recruiting |
NCT02539082 -
the Safety and Efficacy of Collagen Injection in Patients With Plantar Fasciitis
|
Phase 4 | |
Enrolling by invitation |
NCT01786057 -
Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis
|
Phase 2/Phase 3 |